Strong temporal heterogeneity was observed in one patient (CB1008) with many subclonal SCNAs and ongoing chromosomal instability between samples collected at initial diagnosis or after therapy, but stable detection of a MYCN amplification and loss in 1p36 both at neuroblastoma diagnosis and following therapy. Here, MYCN is linked to neuroblastoma.